Immunotherapy in Prostate Cancer
Journal Title: The Bulletin of Urooncology - Year 2009, Vol 18, Issue 2
Abstract
In recent years, immunotherapy has become an important treatment alternative in the treatment of many cancers. Research on immunotherapy in prostate cancer has been accelerated by obtaining Food and Drug Administration (FDA) approval of sipuleucel-T for asymptomatic or minimal symptomatic metastatic castration-resistant prostate cancer (CRPC). Despite all these developments, the patients in whom these agents should be used, sequential use and combination strategies remain unclear. In this review, mechanisms of action and survival outcomes of different immunotherapeutic agents and therapeutic cancer vaccines in mCRPC are discussed.
Authors and Affiliations
Deniz Bolat MD, Ayfer Haydaroğlu,
Keywords
Related Articles
- EP ID EP48741
- DOI 10.4274/uob.galenos.2018.1142
- Views 289
- Downloads 0
Second Primary Malignant Tumours in Patients with Renal Cell Carcinoma
Objective: The primary aim of our study is to establish the frequency and clinicopathological features of seconder primary malignant tumours (SPMTs) in cases with renal cell carcinoma (RCC). Materials and Methods: Patho...
Acute Ischemic Stroke Following Chemotherapy for Malignant Mixed Testicular Germ Cell Tumour: Does Cisplatin Play a Role?
Among males aged between 15 and 35 years, testicular cancer is the most commonly diagnosed cancer. Testicular germ cell tumours are generally considered curable and respond dramatically to adjuvant treatment. Cisplatin-b...
Current Approach in Radiation Therapy for Prostate Cancer
Prostate cancer is one of the most common malignancies in men. Radiotherapy is one of the main treatment modalities in the treatment of prostate cancer. The reflection of technological advances in the field of radiation...
Laparoscopic Partial Nephrectomy for Renal Angiomyolipoma: A Retrospective Cohort Study
Objective: The aim of this study is to investigate the surgical and functional outcomes of laparoscopic partial nephrectomy (LPN) in patients with renal angiomyolipoma (RAML). Materials and Methods: From April 2014 to F...
Prognostic Significance of Surgical Margin Status and Gleason Grade at the Positive Surgical Margin in Predicting Biochemical Recurrence After Radical Prostatectomy in a Turkish Patient Cohort
Objective: To investigate the prognostic role of positive surgical margin (PSM) features in addition to well-defined risk factors in predicting biochemical recurrence (BCR) after radical prostatectomy. Materials and Met...